![Logo IRB](https://prodcraftsa01.blob.core.windows.net/assets/products/irb-advisor/_contentImage/logo-IRB_2022-06-13-214633_aeuk.png)
IRB Advisor – May 1, 2014
May 1, 2014
View Issues
-
To return or not to return? The debate over incidental findings
As technology in genetic and genomic research expands, most if not all IRBs will face the issue of incidental findings, including how to manage them, and whether researchers have a duty to report them to study participants, experts say. -
Report gives IRBs guidance on IFs
There are no industry standards for handling incidental findings (IFs) in research. -
IRB reins in complicated, unwieldy IC forms
An IRB member and human research protection expert learned firsthand how complicated informed consent (IC) forms could be when her granddaughter was seriously ill. -
Suggestions from IC template guidance
The Cincinnati Childrens Hospital Medical Center IRB and a special task force developed guidance and a template for improving and simplifying informed consent forms. -
Case studies clarify social, behavioral risks
IRBs often struggle with determining risks of social and behavioral research studies. Its easy to be both too cautious and too complacent. -
Accreditation expert offers assessment tips
One chief hurdle in human research protection program (HRPP) accreditation is the mindset that its all about the IRB, an expert says. -
Study: Registration data still incomplete
While the informational quality of internationally registered trials has increased, theres still room for improvement, according to a recent study. -
Smartphones pose new ethical challenges
The exponential increase in smartphones and social networking sites has led to concerns from some patients regarding the possible unlawful distribution of images outside the realms of their care.